Top of this page
Skip navigation, go straight to the content
Our Science
•
Olokizumab
Clinical Study Information - olokizumab
| Disease area studied |
Abbreviated title | Phase | Study ID | Registry database | Study results | Lay summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Crohn's Disease | A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease |
CD0001 Terminated |
NCT01635621 2011-002517-11 |
||||
| Rheumatoid Arthritis | Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy |
RA0056 Completed |
NCT01242488 2010-020839-39 |
Genovese, M. C. et al. Ann Rheum Dis;2014;73;9;1607-1615 | |||
| Rheumatoid Arthritis | Open-label Study to Assess the Safety and Efficacy of CDP6038 in Patients Who Completed RA0056 |
RA0057 Completed |
NCT01296711 2010-022224-77 |
||||
| Rheumatoid Arthritis | Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy |
RA0083 Completed |
NCT01463059 | Takeuchi, T.et al. Mod Rheumatol;9-10-2015;1-9 | |||
| Rheumatoid Arthritis | The Long-term Safety and Efficacy of Olokizumab (CDP6038) With Active Rheumatoid Arthritis |
RA0089 Completed |
NCT01533714 |